Results 41 to 50 of about 877 (137)
Occurrence of bioprosthetic valve thrombosis less than a year after replacement is very uncommon. Here, we describe a case of a 57 year old male, who presented 10 months after receiving a bioprosthetic mitral valve replacement with a two week history of ...
Ku Melvin +3 more
doaj +1 more source
Dynamic Echocardiographic Imaging of a Valve-in-Valve Mitral Prosthesis
Dynamic imaging of heart valves and specifically prosthetic valves is a central benefit of echocardiography. Most bioprosthetic heart valves degenerate over a given time and hence require repeat valve replacement which carries a significant risk of ...
Bishoy Wassef +4 more
doaj +1 more source
A 78-year-old woman with bioprosthetic mitral valve degeneration at high risk for reoperation was referred for transcatheter mitral valve replacement. We describe the use of a preemptive alcohol septal ablation pre-procedurally to minimize the risk of ...
Pedro Engel Gonzalez, MD +4 more
doaj +1 more source
Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery
ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili +2 more
wiley +1 more source
PurposeWe examined trends, characteristics and in-hospital outcomes in mechanical and bioprosthetic surgical mitral valve replacement (SMVR) among patients with and without chronic obstructive pulmonary disease (COPD) in Spain from 2001 to 2015.
Javier de-Miguel-Díez +6 more
doaj +1 more source
Effects of Bioprosthetic Valve Fracturing on Valve-in-Valve Transcatheter Aortic Valve Implantation Transvalvular Gradients [PDF]
Background: Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) is quickly becoming a routine and effective means by which to treat degenerated bioprosthetic valves.
Osama Hallak, MD +6 more
doaj +1 more source
Subclinical Valve Thrombosis in Sutureless Bioprosthetic Valves
In the current issue of JAHA , Dalen et al[1][1] report the results of a single‐center prospective observational study of 47 patients with implantation of the Perceval sutureless bioprosthesis (LivaNova, Milan, Italy).
Bobby Yanagawa +2 more
openaire +3 more sources
ABSTRACT Hepatic AL amyloidosis can cause severe cholestasis independent of marrow tumor burden. In patients with absolute contraindications to high‐dose steroids—such as steroid‐induced psychosis—tailored daratumumab regimens with low‐dose corticosteroids can drive rapid, life‐saving organ reversal.
R. Ceccarelli +8 more
wiley +1 more source
ABSTRACT Prosthetic heart valve development consists of several branching, innovative strategies to mediate the complex native environment that wears down valve durability. Anti‐calcification treatments are being applied to pericardial tissue, durable polymers are being developed that mitigate oxidative degradation and stress cracking, and heart valve ...
Drake D. Pedersen +12 more
wiley +1 more source
Bioprosthetic surgical aortic valve failure requiring reintervention is a frequent clinical problem with event rates up to 20% at 10 years after surgery. Transcatheter aortic valve-in-valve implantation (ViV-TAVI) has become a valuable treatment option for these patients, although it requires careful procedural planning. We here describe and illustrate
Vanhaverbeke, Maarten +2 more
openaire +6 more sources

